Preoperative Short‐Term Restriction of Sulfur‐Containing Amino Acid Intake for Prevention of Acute Kidney Injury After Cardiac Surgery: A Randomized, Controlled, Double‐Blind, Translational Trial

Thomas Osterholt,Claas Gloistein,Polina Todorova,Ingrid Becker,Katja Arenskrieger,Ramona Melka,Felix C. Koehler,Michael Faust,Thorsten Wahlers,Thomas Benzing,Roman‐Ulrich Müller,Franziska Grundmann,Volker Burst

DOI: https://doi.org/10.1161/JAHA.121.025229

2022-09-04

Abstract:Background Acute kidney injury (AKI) is a major risk factor for chronic kidney disease and increased mortality. Until now, no compelling preventive or therapeutic strategies have been identified. Dietary interventions have been proven highly effective in organ protection from ischemia reperfusion injury in mice and restricting dietary intake of sulfur‐containing amino acids (SAA) seems to be instrumental in this regard. The UNICORN trial aimed to evaluate the protective impact of restricting SAA intake before cardiac surgery on incidence of AKI. Methods and Results In this single‐center, randomized, controlled, double‐blind trial, 115 patients were assigned to a SAA‐reduced formula diet (LowS group) or a regular formula diet (control group) in a 1:1 ratio for 7 days before scheduled cardiac surgery. The primary end point was incidence of AKI within 72 hours after surgery, secondary end points included increase of serum creatinine at 24, 48, and 72 hours as well as safety parameters. Quantitative variables were analyzed with nonparametric methods, while categorical variables were evaluated by means of Chi‐square or Fisher test. SAA intake in the group with SAA reduced formula diet was successfully reduced by 77% (group with SAA reduced formula diet, 7.37[6.40–7.80] mg/kg per day versus control group, 32.33 [28.92–33.60] mg/kg per day, P <0.001) leading to significantly lower serum levels of methionine. No beneficial effects of SAA restriction on the rate of AKI after surgery could be observed (group with SAA reduced formula diet, 23% versus control group, 16%; P =0.38). Likewise, no differences were recorded with respect to secondary end points (AKI during hospitalization, creatinine at 24, 48, 72 hours after surgery) as well as in subgroup analysis focusing on age, sex, body mass index and diabetes. Conclusions SAA restriction was feasible in the clinical setting but was not associated with protective properties in AKI upon cardiac surgery. Registration URL: https://www.clinicaltrials.gov; Unique Identifier: NCT03715868. Nonstandard Abbreviations and Acronyms AKI acute kidney injury CG control group CR calorie restriction IGFBP7 Insulin Like Growth Factor Binding Protein 7 SAA sulfur‐containing amino acids TIMP‐2 Tissue inhibitor of metalloproteinases 2 TSP transsulfuration pathway Clinical Perspective What Is New? To our knowledge, the UNICORN trial is the first study assessing the potential benefit of restricting sulfur‐containing amino acids for organ protection in humans. In this single‐center, randomized, controlled, double‐blind trial a 7‐day restriction of sulfur‐containing amino acids did not ameliorate acute kidney injury after cardiac surgery. What Are the Clinical Implications? A deeper mechanistic insight is necessary to translate the findings elicited by cysteine and methionine restriction in animals into the human setting. As this study cannot report a beneficial effect of restriction of sulfur‐containing amino acids on acute kidney injury in humans, further studies should rather focus on pharmacological approaches that activate underlying, evolutionary conserved mechanisms of enhanced stress resistance. With an incidence of up to 40%, acute kidney injury (AKI) is a frequently encountered complication after cardiac surgery. 1 , 2 , 3 Even mild cases are associated with a longer hospital stay, higher morbidity, and increased short‐term as well as long‐term mortality. 4 , 5 , 6 Despite several clinical trials using pharmacological agents, the quest for an effective reno‐protective treatment has not been successful to date. 1 In recent years, promising and innovative nonpharmacological strategies to enhance cellular resilience have emerged—remote ischemic preconditioning being the mos -Abstract Truncated-